Alogabat

N/A

Report date: 2024/05/17 14:25:51
NME

Base Information

Drug NameAlogabat
Drug Alias NameRG-7816RO-7017773RG7816 alogabatGABA-Aa5 PAM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor alpha-5 modulators
TargetsGamma-aminobutyric acid A receptor alpha-5
Therapy Area/IndicationsAutistic DisorderAutism Spectrum DisorderAngelman Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsAutistic DisorderAutism Spectrum DisorderAngelman Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A